2024 annual financial data
Traws Pharma 2024 Net margin
Direct answer
Net margin was -24,192.04%.
Operating income was -49,348,000 USD and net income was -54,674,000 USD.
Operating cash flow was -29,792,000 USD.
Get free Traws Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 226,000 USD
- Operating income
- -49,348,000 USD
- Net income
- -54,674,000 USD
- Operating cash flow
- -29,792,000 USD